411 related articles for article (PubMed ID: 35419709)
1. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases.
Hasanvand A
Inflammopharmacology; 2022 Jun; 30(3):775-788. PubMed ID: 35419709
[TBL] [Abstract][Full Text] [Related]
2. Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.
Bang S; Chen Y; Ahima RS; Kim SF
Mol Endocrinol; 2014 Jul; 28(7):1186-93. PubMed ID: 24877601
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
4. Metformin and cancer.
Vallianou NG; Evangelopoulos A; Kazazis C
Rev Diabet Stud; 2013; 10(4):228-35. PubMed ID: 24841876
[TBL] [Abstract][Full Text] [Related]
5. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
Rattan R; Giri S; Hartmann LC; Shridhar V
J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
[TBL] [Abstract][Full Text] [Related]
6. Role of AMP-activated protein kinase in mechanism of metformin action.
Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase in metabolic control and insulin signaling.
Towler MC; Hardie DG
Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
[TBL] [Abstract][Full Text] [Related]
8. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.
Stephenne X; Foretz M; Taleux N; van der Zon GC; Sokal E; Hue L; Viollet B; Guigas B
Diabetologia; 2011 Dec; 54(12):3101-10. PubMed ID: 21947382
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
10. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex.
Meng S; Cao J; He Q; Xiong L; Chang E; Radovick S; Wondisford FE; He L
J Biol Chem; 2015 Feb; 290(6):3793-802. PubMed ID: 25538235
[TBL] [Abstract][Full Text] [Related]
11. The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production.
An H; Wang Y; Qin C; Li M; Maheshwari A; He L
Sci Rep; 2020 Jun; 10(1):10482. PubMed ID: 32591547
[TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
13. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
15. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).
Cao J; Meng S; Chang E; Beckwith-Fickas K; Xiong L; Cole RN; Radovick S; Wondisford FE; He L
J Biol Chem; 2014 Jul; 289(30):20435-46. PubMed ID: 24928508
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional regulation of adenosine 5'-monophosphate-activated protein kinase activity by berberine and metformin in response to changes in ambient glucose concentration.
Xiao Y; Xu M; Alimujiang M; Bao Y; Wei L; Yin J
J Cell Biochem; 2018 Dec; 119(12):9910-9920. PubMed ID: 30129983
[TBL] [Abstract][Full Text] [Related]
17. Metformin interacts with AMPK through binding to γ subunit.
Zhang Y; Wang Y; Bao C; Xu Y; Shen H; Chen J; Yan J; Chen Y
Mol Cell Biochem; 2012 Sep; 368(1-2):69-76. PubMed ID: 22644486
[TBL] [Abstract][Full Text] [Related]
18. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.
Dutta S; Shah RB; Singhal S; Dutta SB; Bansal S; Sinha S; Haque M
Drug Des Devel Ther; 2023; 17():1907-1932. PubMed ID: 37397787
[TBL] [Abstract][Full Text] [Related]
19. Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.
Galdieri L; Gatla H; Vancurova I; Vancura A
J Biol Chem; 2016 Nov; 291(48):25154-25166. PubMed ID: 27733682
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
